Quell Therapeutics Ltd (“Quell”), a leader in developing engineered T-regulatory (Treg) cell therapies for serious ...
I’ve been fortunate to invest in several AI funding rounds—from pre-seed to Series B to F—and to see up close how billions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results